Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

SNM debuts its Molecular Imaging Gateway, an exhibit area devoted to new technologies and applications in the evolving field of molecular imaging, at its 54th Annual Meeting 2-6 June in Washington, D.C. SNM debuts its Molecular Imaging Gateway, an exhibit area devoted to new technologies and applications in the evolving field of molecular imaging, at its 54th Annual Meeting 2-6 June in Washington, D.C.

“SNM recognizes the expanding role of molecular imaging in 21st century patient care and wants to ensure that the medical community is well prepared to adopt these new advances,” said SNM President Martin P. Sandler. Molecular imaging is the use of state-of-the-art imaging technologies (such as PET, SPECT, MRI and others) to see, define and determine the biology of disease, potentially revolutionizing patient care by providing a better way to diagnose, treat and manage cancer, heart disease and brain disorders,” noted the associate vice chancellor for hospital affairs for Vanderbilt University Medical Center in Nashville, Tenn. “SNM—the world’s largest society for molecular imaging and nuclear medicine—invited world-class molecular imaging academic institutions, professional societies and government agencies to showcase the most current work in this field at its meeting,” he added.

“The Molecular Imaging Gateway will provide attendees with an opportunity to learn about different imaging modalities in addition to traditional nuclear medicine,” said MICOE President Martin G. Pomper. “Our inaugural Molecular Imaging Gateway demonstrates the collaborative approach that is necessary to take breakthroughs in molecular imaging into the clinical environment—and bring these advances to a wider audience,” said the associate professor of radiology at Johns Hopkins Medical Institutions in Baltimore, Md.

Displays are expected to feature the latest information on:

• PET, SPECT, CT, MRI, MRS, optical, ultrasound and hybrid imaging
  
• existing and emerging molecular imaging agents, probes and therapies
  
• biological and technological innovations in molecular imaging
  
• applications of and relevance of molecular imaging to different diseases
  
• applications of molecular imaging to basic research, translational research, clinical use, and drug development
  
• funding, grant, and award opportunities in molecular imaging
  
• training and educational opportunities in molecular imaging.

To date, exhibitors include representatives from the Crump Institute of Preclinical Imaging, Emory University, Johns Hopkins University, Stanford University, University of Texas M.D. Anderson Cancer Center, VA Biomolecular Imaging Center, University of California–Davis, University of Missouri–Columbia, VCU Molecular Imaging Center, Washington University Molecular Imaging Center, Washington University School of Medicine, the National Cancer Institute, Japanese Society of Molecular Imaging, Academy of Molecular Imaging, Society for Molecular Imaging and the Radiological Society of North America.

More than 4,000 doctors, technologists, scientists and pharmacists from around the world will attend SNM’s Annual Meeting, and nearly 2,000 scientific and technologist studies will be presented during SNM’s Annual Meeting, offering a look at molecular imaging and nuclear medicine research leading to improvements in the diagnosis and treatment of life-threatening cancer, heart disease and brain disorders. The Molecular Imaging Gateway is sponsored by the society’s Molecular Imaging Center of Excellence. To register for the meeting, visit the SNM website at http://www.snm.org/am.